---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-056736"
form_type: "8-K"
ticker: "APVO"
cik: "0001671584"
company_name: "Aptevo Therapeutics Inc."
filed_at: "2025-04-22T23:59:59+00:00"
generated_at: "2026-05-23T09:23:19.323422+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Aptevo raises $2.0M in registered direct offering at $0.862/share

## Summary
- Sold 2,324,000 shares at $0.862 each, gross proceeds ~$2.0M; net ~$1.8M after fees.
- Roth Capital Partners acted as exclusive placement agent, receiving 7.0% cash fee.
- Proceeds to fund clinical programs, working capital, and general corporate purposes.
- Offering closed April 22, 2025; 5-day lockup on further equity issuance following close.

## SEC filing metadata
- accession: 0000950170-25-056736
- form_type: 8-K
- ticker: APVO
- cik: 0001671584
- company_name: Aptevo Therapeutics Inc.
- filed_at: 2025-04-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671584/000095017025056736/0000950170-25-056736-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671584/000095017025056736/apvo-20250421.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-056736
- JSON: https://secwatch.observer/filing/0000950170-25-056736.json
- Plain text: https://secwatch.observer/filing/0000950170-25-056736.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.